Header Logo

Kathleen Moore

Concepts (297)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Kathleen Moore's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Kathleen Moore has written about over time.
Uterine Cervical Neoplasms, 14 publications between 2003 and 2020, average publication date September 2012. Endometrial Neoplasms, 9 publications between 2009 and 2018, average publication date July 2014. Middle Aged, 47 publications between 2003 and 2024, average publication date November 2015. Fallopian Tube Neoplasms, 8 publications between 2005 and 2020, average publication date March 2016. Female, 72 publications between 2003 and 2024, average publication date April 2016. Neoplasm Recurrence, Local, 11 publications between 2007 and 2024, average publication date August 2016. Antineoplastic Combined Chemotherapy Protocols, 24 publications between 2007 and 2021, average publication date December 2016. Antineoplastic Agents, 10 publications between 2013 and 2021, average publication date September 2017. Ovarian Neoplasms, 39 publications between 2005 and 2024, average publication date March 2018. Clinical Trials as Topic, 7 publications between 2014 and 2024, average publication date July 2018. Indazoles, 5 publications between 2018 and 2020, average publication date January 2019. Piperidines, 5 publications between 2018 and 2020, average publication date January 2019. Peritoneal Neoplasms, 6 publications between 2017 and 2020, average publication date March 2019. Poly(ADP-ribose) Polymerase Inhibitors, 11 publications between 2016 and 2021, average publication date July 2019. Piperazines, 6 publications between 2016 and 2021, average publication date July 2019. Phthalazines, 7 publications between 2016 and 2021, average publication date November 2019. Antibodies, Monoclonal, Humanized, 8 publications between 2012 and 2024, average publication date January 2020. Immunoconjugates, 5 publications between 2018 and 2024, average publication date May 2021. Maytansine, 3 publications between 2018 and 2024, average publication date July 2021.

To see the data from this visualization as text, click here.
Moore's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (297)
Explore
_
Co-Authors (30)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_